Select Medical (SEM) to Release Quarterly Earnings on Thursday

Select Medical (NYSE:SEM) will likely be releasing its Q4 2025 results after the market closes on Thursday, February 19th. Analysts expect the company to announce earnings of $0.23 per share and revenue of $1.3641 billion for the quarter. Individuals can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Friday, February 20, 2026 at 9:00 AM ET.

Select Medical Stock Performance

SEM stock opened at $16.22 on Thursday. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.87. The firm has a market cap of $2.01 billion, a PE ratio of 18.86, a P/E/G ratio of 0.56 and a beta of 1.25. The business’s 50-day moving average price is $15.17 and its two-hundred day moving average price is $13.95. Select Medical has a 1-year low of $11.65 and a 1-year high of $19.54.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the company. Benchmark reaffirmed a “buy” rating on shares of Select Medical in a report on Monday, October 27th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Select Medical in a research note on Wednesday, January 21st. Wall Street Zen upgraded Select Medical from a “hold” rating to a “buy” rating in a research report on Saturday, November 8th. Finally, Mizuho set a $17.00 target price on Select Medical in a report on Monday, November 3rd. Four investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $17.80.

Institutional Investors Weigh In On Select Medical

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Quantbot Technologies LP acquired a new stake in shares of Select Medical in the 3rd quarter worth $27,000. Wilmington Savings Fund Society FSB raised its stake in Select Medical by 20.9% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 5,784 shares of the health services provider’s stock valued at $74,000 after acquiring an additional 999 shares during the last quarter. Quadrant Capital Group LLC purchased a new position in Select Medical in the third quarter worth $93,000. iSAM Funds UK Ltd purchased a new stake in shares of Select Medical in the third quarter valued at about $96,000. Finally, CIBC Bancorp USA Inc. acquired a new position in Select Medical in the 3rd quarter valued at $153,000. Hedge funds and other institutional investors own 89.48% of the company’s stock.

Select Medical Company Profile

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.